This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

EMD Serono has decided to permanently terminate the trial EMR 200038-010 (STRIDE) in the indication of breast cancer following the clinical hold on the investigational new drug application for tecemotide (L-BLP25).

Provided treatments

  • Biological: Tecemotide (L-BLP25) and Hormonal Treatment
  • Biological: Placebo of tecemotide (L-BLP25) and Hormonal Treatment
  • Drug: cyclophosphamide
  • Drug: sodium chloride (NaCl)
Tris trial is registered with FDA with number: NCT00925548. The sponsor of the trial is EMD Serono and it is looking for 16 volunteers for the current phase.
Official trial title:
A Randomized, Double-blind, Controlled Phase III Study of Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Combination With Hormonal Treatment Versus Hormonal Treatment Alone for First-line Therapy of Post-menopausal Women With Estrogen Receptor (ER)-Positive and/or Progesterone Receptor (PgR)-Positive, Inoperable Locally Advanced, Recurrent, or Metastatic Breast Cancer